The 7th China IVD Distribution Enterprise Forum is set to take place on 23 March 2025, at the Hangzhou Grand Convention and Exhibition Center.
Under the theme "Gathering new momentum · Co-creating a new chapter in IVD distribution", this forum has invited renowned domestic experts, executives from listed companies, and leaders of third-party service organizations to interpret economic policies and macroeconomic trends. It aims to help enterprises strengthen their development confidence, seize market opportunities, and provide a platform for communication and collaboration among distribution companies, fostering mutual growth and success. This forum aims to explore:
· new industry trends and business strategies
· digital transformation
· international cooperation and global expansion
· smart healthcare and new quality productivity
.......
TIME (UTC+8)
13:15-18:20 | 23 March 2025, Sunday
LOCATION
Conference Hall A3
1st Floor, Hall 1 (Convention Center)
Hangzhou Grand Convention & Exhibition Center
CONCURRENT EVENT HIGHLIGHTS
· The 22nd China International In Vitro Diagnostic Expo by CACLP
· The 5th China IVD Supply Chain Expo (CISCE)
· The 12th China IVD Industry Development Conference
· The 10th China Experimental Medicine Conference
· PCEM Series Sessions (Pathology, Molecular, Mass Spectrometry, Blood Transfusion, Laboratory Management, etc.)
· The 5th IVD China Key Raw Material & Parts Forum
· AI and Digital Twin Technology Salon
ORGANIZATION STRACTURE
· Honorary Chairman: Prof. Haibo SONG, Prof. Liang YIN
· Chairman: Ms. Fang LI
· Executive Chairman: Mr. Youbin QIU, Mr. Chi MA, Mr. Hongyue YU, Mr. Shenghui JI
ORGANIZER:
Conference registration now available.
Copyright © 2025 GL events Ruihe (Shanghai) Exhibition Co., Ltd. All Rights Reserved. ( 沪ICP备12004745号-1 )
We deliver the latest IVD news straight to your inbox. Stay in touch with CACLP News.
sign-up for our newsletter today.
To ensure our newsletter hit your inbox, make sure to add @caclp.com to your safe senders list. And, as always, feel free to contact
us with any questions and thanks again for subscribing.